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Volume 58, Number 2 Abstracts 565(BM) balloon expandable stents in the treatment of common iliac artery
disease. This study was performed to evaluate midterm outcomes of bare
metal vs covered balloon expandable stents for treatment of aortoiliac
(AI) occlusive disease.
Methods: All AI endovascular interventions for symptomatic periph-
eral arterial occlusive disease performed at a single institution from 2006-
2012 were reviewed. Patients that underwent stent placement in the
common iliac arterial segment were included in the analysis. Demographic
data, TransAtlantic Inter-Societal Classiﬁcation (TASC), stent type, patency,
and all reinterventions for each limb were compared.
Results: 188 procedures in 124 patients were performed for treat-
ment of de novo distal aorta and/or common iliac artery stenosis. Bare
metal balloon expandable stents were used in 135 arteries, and covered
balloon expandable stents were used in 53 arteries. There was no difference
in age, gender, or TASC classiﬁcation between the two groups. Table I.
Median follow up was 1.7 years (IQR, 0.6-3.0). There was no difference
in overall primary or primary assisted patency between the two groups.
Table II. Secondary patency was signiﬁcantly better in the covered stent
group, however, common Iliac arteries treated with covered stents were
more likely at 1 year and beyond to require repeat aortoiliac intervention
(HR, 2.6; 95% CI, 1.13-6.0; P ¼ .02; Fig). TASC classiﬁcation did not
predict need for reintervention in either group.
Conclusions: In the current study, covered stents have improved
secondary patency over bare metal stents for treatment of AI occlusive
disease, at the expense of increased reinterventions. The difference in
secondary patency may be due to more focal, edge restenosis in covered
stents vs diffuse restenosis in bare metal stents.
Fig.
Table I. Demographic characteristics of treated lesions
Overall Bare metal Covered P valueAge (mean 6 SD) 64 6 11 64 6 12 65 6 11 .5
TASC A (%) 54 (45) 39 (43) 15 (52) .57
TASC B 56 (30) 41 (30) 15 (28) .99
TASC C 41 (22) 30 (22) 11 (21) .98
TASC D 36 (19) 24 (18) 12 (23) .58Table II. Patency of treated lesions
n ¼ 188 Overall Bare metal Covered P valuePrimary patency (%) 121 (75) 86 (75) 35 (74) .99
Primary assisted patency 136 (84) 93 (82) 43 (91) .18
Secondary patency 140 (87) 94 (82) 46 (98) .02The Diagnostic Triad of Orphan Heel Syndrome: Posterior Tibial and
Peroneal Artery Occlusive Disease, Poorly Controlled Diabetes, and
Renal Failure
Zack Taylor Sr, MD. Vascular Surgery, University of Arizona, Tucson, Ariz
Objectives: Large heel ulcers represent enormous challenges. Limb
preservation is difﬁcult in these patients, who often suffer from diabetes,
renal failure and calciﬁed, distal arterial occlusive disease. Traditional non-
invasive studies including ankle-brachial indices and toe-pressures may not
accurately predict healing. The purpose of this study was to assess the valueof traditional noninvasive studies, limb salvage rate and healing time in
patients with full thickness heel ulcers.
Methods: From 2009-2011, a single interdisciplinary limb salvage unit
evaluated 21 consecutive patients with deep heel ulcers requiring operative
debridement. Pertinent comorbidities including diabetes and renal insufﬁ-
ciency were noted. Investigators blinded to the clinical course reviewed all
studies. Wound healing times and limb salvage rates were calculated.
Results: Among the 21 patients, 10 (48%) had CKD (7 on dialysis; 3
Stage 3/4 CKD); 18/21 (86%) were known diabetics at the time of presen-
tation; all patients had HgbA1c > 9 and in 8/21, HgbA1c exceeded 11.
Serum albumin levels were uniformly low (range, 1.4-4). 66.7% had normal
ABIs (range, 0.8-1.2). ABIs were noncompressible in 23.8% of patients.
Only two patients had low ABIs (0.28 and 0.39). Healing occurred in 13/
21 patients over a mean of 251 days (range, 42-540); the remainder died
of comorbidities before healing (1), underwent major amputation (3), or
were lost to follow up (4). ABIs and TPs did not correlate with healing. Eight
patients with normal forefoot perfusion by noninvasive testing had severe heal
malperfusion by angiography; 53% (10) patients underwent angiography and
7 underwent revascularization, primarily endovascular.
Conclusion: In this patient group, the heel is frequently ischemic even
in the presence of a palpable DP pulse and normal forefoot noninvasive
testing. This is due to an unusual pattern of occlusive disease that dispropor-
tionately involves the posterior tibial and pedal arch vessels, (the heel circula-
tion is compartmentalized from the forefoot) a condition termed orphan heel
syndrome. It is also associated with uncontrolled diabetes and renal failure.
Even with aggressive care, healing times are prolonged. Early angiography
and heel revascularization is recommended in functional patients with this
clinical triad.
Adjunctive Dexamethasone Infusion into the Adventitia of the Femoro-
popliteal Artery to Enhance Clinical Efﬁcacy Following Endovascular
Revascularization: A Proof of Concept First in Man Study
Christopher D. Owens,1 Warren Gasper,1 Hugh F. Alley,1 Karen C.
Chong,1 Joseph H. Rapp,1 Michael S. Conte,1 Kirk Seward,2 Marlene S.
Grenon1. 1University of California, San Francisco, San Francisco, Calif;
2Mercator MedSystems, San Leandro, Calif
Objectives: Restenosis following peripheral intervention is in part an
inﬂammatory disease. We hypothesize that a non-stent-based local drug
delivery of the anti-inﬂammatory corticosteroid dexamethasone (DEX)
would mitigate intervention-associated inﬂammation and thus improve
long-term arterial patency.
Methods: This was an investigator initiated pilot study to determine if
percutaneous adventitial drug delivery was safe and feasible in human
peripheral arteries. Following successful intervention, an adventitial micro-
infusion catheter (MIC) was advanced over a 0.014” wire to the treated
segment. Its micro-needle was deployed into the adventitia to deliver
DEX (4 mg/mL) mixed with contrast agent providing ﬂuoroscopic visual-
ization. The safety outcome was freedom from vessel dissection, thrombosis
or extravasation, while the primary efﬁcacy outcome was duplex-determined
binary restenosis deﬁned as PSVR >2.4 of the treated segment.
Results: 21 patients with Rutherford classiﬁcation 2-5 enrolled in this
study and followed for a median of 335 days. Mean age was 65.9 and 57.1%
were diabetic. Treated lesion length was 8.7 6 5.2 cm and 48% were
chronic total occlusions. 80% of treated lesions were in the distal SFA/popli-
teal artery. The average preoperative Rutherford score was 3.77 6 .8. All
lesions were treated by balloon angioplasty with provisional stenting for
suboptimal result. 11.5 6 5.7 mg of dexamethasone was injected into the
adventitia of the treated lesions. There was 100% technical success of
drug delivery and no procedural or drug-related adverse events. Rutherford
score at last available follow-up was .466 .74 (P < .001) and ABI improved
from .68 6 .15 to .95 6.18 (P < .001). Postprocedural C-reactive protein
(CRP) was not signiﬁcantly different from baseline CRP (P ¼ .13). Two
patients developed binary restenosis of the index lesion during the follow-
up period.
Conclusions: Adventitial drug delivery via the MIC is a safe and
feasible alternative to intimal-based methods. These preliminary data suggest
that perivascular DEX treatment may improve outcomes following angio-
plasty to the distal femoro-popliteal segment. Further study is warranted to
establish efﬁcacy for anti-inﬂammatory treatment following angioplasty.
Demographic and Echocardiographic Predictors of Anatomic Site and
Outcomes of Interventions for Cardiogenic Peripheral Emboli
Gregory Landry, MD, Rakendu Shukla, Timothy Liem, MD, Erica
Mitchell, MD, Amir Azarbal, MD, Greg Moneta, MD. Oregon Health &
Science University, Portland, Ore
Objectives: The association between demographic and echocardio-
graphic ﬁndings with the site of cardiogenic peripheral embolization is
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distribution or if there are factors that predict site of embolization, limb
salvage and mortality.
Methods: Upper (UE) and lower extremity (LE) emboli were evalu-
ated over a 6 year period. Demographic (age, gender, smoking, medical
comorbidities) and echocardiographic data were analyzed to determine
predictors of embolic site. All patients underwent surgical revascularization.
Limb salvage and mortality were compared with Kaplan-Meier analysis.
Results: 160 patients (72 male, 88 female) with presumed cardiogenic
emboli were identiﬁed, 56 UE (35 right, 21 left) and 104 LE (42 right, 44
left, 18 bilateral). Men had signiﬁcantly higher LE emboli than females
(76% vs 56%) and females more UE (44% vs 24%; P ¼ .01). No other demo-
graphic factors were statistically different. UE patients were more likely to
have atrial ﬁbrillation on admission (50% vs. 30%; P ¼ .04), while there was
a trend towards LE patients having a higher percentage of aortic or mitral
valvular disease (47% vs 31%; P ¼ .06). 30 day limb salvage was higher for
UE compared to LE (100% vs 88%; P ¼ .008) There was a trend toward
higher 30 day mortality in the LE group (14% vs 5%; P ¼ .08). One year
mortality in both groups was approximately 25%.
Conclusions: UE emboli are more frequent in women and patients
with active atrial ﬁbrillation. LE emboli are more frequent in men and
patients with valvular disease, and are associated with increased 30 day
limb loss and mortality. These ﬁndings suggest gender- and cardiac-speciﬁc
differences in patterns of blood ﬂow leading to preferential sites of periph-
eral embolization.
Beyond Arterial Stenosis: Walking Disability in PAD Patients Is
Related to Arterial Endothelial Function
Christopher D. Owens, Hugh F. Alley, Karen C. Chong, Jade S. Hiramoto,
Michael S. Conte, Joseph H. Rapp, Marlene S. Grenon. University of
California, San Francisco, San Francisco, Calif
Objectives: Patients with peripheral artery disease (PAD) have varying
degrees of walking disability that do not completely correlate with ankle
brachial index (ABI) or angiographic anatomy. We hypothesized that endo-
thelial function (EF) is an independent predictor of symptom severity in
PAD patients.
Methods: This was a prospective cohort study of PAD patients
(n ¼ 100) presenting to a vascular surgery clinic. All patients received ABIs
and brachial artery ﬂow-mediated, endothelium-dependent, vasodilation
(FMD) to assess arterial EF. PAD severity was assessed by the clinical Ruth-
erford score. Demographic, biochemical and physiologic parameters were
entered into regression equations to determine association with disease
severity.
Results: Mean age was 66.3 6 8.2 and 43% had diabetes. Mean FMD
was 7.3% indicating impaired EF. EF progressively declined as Rutherford
score increased (P < .0001). Diabetes mellitus, albumin, CRP, homocys-
teine, total cholesterol, and hgbA1c, were all associated with Rutherford
score (all P < .05). After multivariable regression, EF (P < .0001), ABI
(P < .0001), and total cholesterol (P ¼ .033) were predictive of walking
disability. Combined, EF, ABI, and total cholesterol account for 50% of the
variability in Rutherford scores. However EF and ABI were not correlated
indicating that they are independent predictors of disability. When the cohort
was restricted to claudicants (n ¼ 81), EF was equally predictive of walking
disability. Homocysteine was inversely associated with EF (P ¼ .024).
Patients with hyperhomocysteinemia (>15 mmol/L; n ¼ 41) had lower EF
(P ¼ .04) and higher Rutherford scores (P ¼ .017) than those without.
Conclusion: Symptom severity in PAD is multifactorial, reﬂecting
both impaired hemodynamics and vascular dysfunction. This is the ﬁrst
demonstration that walking disability in PAD is associated with arterial
EF. Endothelial dysfunction in this cohort may be related to homocys-
teine-dependent mechanisms by reducing bioavailable nitric oxide.
Prospective Evaluation of Tissue Perfusion in Patients with Peripheral
Arterial Disease Using Laser-Assisted Fluorescent Angiography
Venita Chandra, MD, Mohamed Zayed, MD, PhD, Elizabeth
Hitchner, MS, Vinit N. Varu, MD, Oliver Aalami, MD, Wei Zhou, MD.
Vascular Surgery, Stanford University Medical Center, Stanford, Calif
Objectives: Laser-assisted ﬂuorescent angiography (LAFA) has been
used by many specialties to evaluate end organ tissue perfusion. We hypoth-
esize that LAFA can be a valuable tool to qualitatively and quantitatively
assess distal perfusion in patients with peripheral arterial disease (PAD).
Using this technology we prospectively evaluated PAD patients pre- and
postvascular interventions.
Methods: Patients undergoing interventions for PAD were prospec-
tively recruited into this IRB approved pilot study. Plantar pedal perfusion
was analyzed pre- and postvascular intervention using the SPY Elite
LAFA system (Lifecell Corporation). Topographical and ﬂuorescentimages were obtained for each patient pre- and postvascular intervention
(Fig). Peak pedal perfusion and ingress slope (rate of inﬂow) were derived
from the recorded images. Ankle brachial indices (ABIs) were also evaluated
pre- and postintervention. Statistical analysis was performed using Student’s
t-test and Pearson correlation.
Results: Twenty-seven patients with PAD comprised the study pop-
ulation, with an average age of 68. The majority of patients had Ruther-
ford class 5 critical limb ischemia (55%) and one vessel tibial runoff
(61%). The majority of patients underwent endovascular femoral and
popliteal interventions (88%). Postintervention signiﬁcant increases were
seen in pedal ﬂuorescent ingress slopes (P ¼ .03) and a similar increase
in ABIs (P ¼ .001). Peak pedal perfusions increased in 66% of patients
by an average of 45.8%. Both peak pedal perfusion and ingress slope corre-
lated with postintervention ABI (R2¼.56 and R2¼.58, respectively). Peak
pedal perfusion and ingress slope also demonstrated a moderate correla-
tion (R2¼.75).
Conclusions: This prospective pilot study demonstrates feasibility and
utility of LAFA in the perioperative evaluation of PAD patients. Qualitative
and quantitative ﬂuorescent images provide real-time and objective assess-
ments of pedal tissue perfusion. LAFA-derived peak pedal perfusion and
ingress slope provide objective measurements of tissue perfusion that corre-
late with conventional methods using ABIs. With further study, we antici-
pate that this technology may be a helpful adjunct for intraoperative
decision making and predicting wound healing capacity.
Superﬁcialization of the Brachial Artery: An Appraisal of Its Value for
Vascular Access
Takashi Nakamura, MD,1 Junichi Nakamura, MD2. 1Osaka Rosai Hospital,
Sakai, Osaka, Japan; 2Tenma Nakamura Clinic, Osaka, Japan
Objectives: The Japanese Society for Dialysis Therapy recommends
superﬁcialization of the brachial artery (BA) as an alternative vascular access
(VA) technique in patients for whom a conventional internal shunt (AVF or
AVG) cannot be created. Although 2-3% of Japanese hemodialysis patients
undergo this procedure, it is not well recognized worldwide. We report here
our experience with the procedure, as well as indications, durability, and
morbidity.
Method: The technique involves exposure of the BA and ligation of
the side branches, then ﬁxing it beneath the skin at the upper arm. Cannu-
lation of the BA is performed 2 weeks or more after surgery and it is used as
an outﬂow route, with any vein in an upper extremity utilized for blood
return, including the hand if sites in the arm are not accessible. We retro-
spectively reviewed our cases of superﬁcialization of the BA for VA.
Results: From 2005-2008, a total of 24 patients (11 females [46%],
average age 69 years [range, 39-84 years]) underwent superﬁcialization of
the BA, of whom 8 (33%) had diabetes. The indications were (1) impaired
cardiac function (n ¼ 13), (2) no other prospect for AVF or patient refused
prosthetic graft implantation (n ¼ 5), (3) severe upper extremity arterial
disease or ischemic steal syndrome requiring AVF closure (n ¼ 3), (4)
venous hypertension with central vein occlusion (n ¼ 2), and (5) repeated
AVF thrombosis due to heparin-induced thrombocytopenia (n ¼ 1). The
mean follow-up period was 28 months. Serious complications were seen
in 1 patient with an infected pseudoaneurysm formation associated with
a BA puncture, which necessitated BA ligation, while we also had difﬁculty
ﬁnding a vein for blood return in 5 patients. The rate of superﬁcialized BA
patency as a functioning VA was 95% and 66% at 1 and 3 years, respectively.
Conclusions: Superﬁcialization of the BA was found to be a simple
and safe technique, with acceptable durability and complication rate in
selected Japanese hemodialysis patients. We consider that this shuntless
VA permits adequate blood ﬂow and has theoretical advantages for some
patients, particularly those with impaired cardiac function, though the avail-
ability of a return vein is a prerequisite for a functioning VA.
Fig.
Long-Term Outcomes with Arteriovenous Fistulas in a Pediatric
Population
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